Open in new window
|
|
Pharmaindustrial News
|
|
FDA Approves Medtronic's Evolut FX+ Transcatheter Aortic Valve Replacement System
With a modified diamond-shaped frame design, the Evolut FX+ offers larger coronary access windows, providing increased space for catheter maneuverability to reach coronary arteries of varying patient...
Read more
|
|
|
FDA Clears PATHFAST hs-cTnI-II Test for Rapid Myocardial Infarction Diagnosis at Point of Care
Prompt diagnosis is crucial in treating patients suspected of having a heart attack.
Read more
|
|
|
Akebia Gains FDA Approval of Vafseo Tablets for Treatment of Anemia
Akebia Therapeutics has declared that the US Food and Drug Administration (FDA) has approved Vafseo (vadadustat) Tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults.
Read more
|
|
|
Integral Molecular Gains ISO 9001 Certification for its MPA Services
Integral Molecular has secured IS0 9001 certification for the quality systems and processes used in its Membrane Proteome Array (MPA) specificity testing services.
<br />
Read more
|
|
|
GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume.
Read more
|
|
|
PhotoPharmics Launches Largest Phototherapy Trial for Parkinson's Disease
The 'Celeste Light for PD Trial' (found at lightforpd.com) represents a significant stride in Parkinson’s disease (PD) treatment, leveraging innovative Spectramax™ technology through the...
Read more
|
|
|
Bridge Biotherapeutics New Venture into Immuno-Oncology with University of Colorado
Bridge Biotherapeutics has forged a research collaboration with Dr. Raul Torres's Lab at the University of Colorado School of Medicine.
Read more
|
|
Articles
|
|
Pharmaceutical Filling Machine for Small and Micro Batch Liquid
While the production of drugs in large quantities used to be the benchmark for decades, today individual therapies are playing an increasingly important role...
Read more
|
|
Interviews
|
|
Phloton: Revolutionizing Last-Mile Immunization and Diagnostics Delivery
Q: Could you please provide an overview of Enhanced Innovations Pvt. Ltd?
Ankita Mittal: Enhanced Innovations is an innovation development and translation...
Read more
|
|
|
Pharma Sector is Poised for Exceptional Growth in the Coming Years
Q: Could you elaborate on the significance of WIKA India's Force Measurement Production Unit in Pune and how it aligns with WIKA's strategic objectives,...
Read more
|
|
|
This message and any attachments are confidential and privileged and intented for the use of the addressee only. If you have received this communication in error, please notify the sender by replay e-mail and delete this message from your system. Please note that Internet e-mail guarantees neither the confidentiality nor the proper receipt of the message sent. The data deriving from our correspondence with you are included in a file of OMNIMEDIA, S.L. which exclusive purpose is to manage the communications of the company; under the understanding that, in maintaining said correspondence, you authorize the treatment of such data for the mentioned purpose. You are entitled to exercise your rights of access, rectification, cancellation and opposition by addressing such written application to address C/ Pollensa, 2, Edif. Artemisa of. 12 de LA ROZAS (28290 - MADRID) enclosing your NIF or identifying document photocopies of.
Unsubscribe
|